The European League Against Rheumatism (EULAR) has published updated recommendations on the management of fibromyalgia. The detailed recommendations can be found in the Annals of the Rheumatic Diseases.
Fibromyalgia is a condition characterized primarily by chronic widespread pain (CWP) in the muscles, ligaments and tendons, and a heightened sensitivity to touch resulting in pain that can last for months.
Common signs and symptoms of fibromyalgia include: Continue reading
Why are we doing this study?
The CIHR Institute of Musculoskeletal Health and Arthritis (IMHA) located at the University of Manitoba is funding a research project to help improve the treatment and quality of life of people with fibromyalgia. Responses to this survey will be used to identify the top research priorities of patients, caregivers and clinicians in the area of fibromyalgia. This study is being led by a steering committee which is made up of patients, caregivers, doctors, researchers, and staff members from CIHR IMHA, and a collaborator from the James Lind Alliance.
With this survey, we are inviting you to share your ideas about research to help improve the treatment and quality of life of people living with fibromyalgia. This survey has been approved by the University of Manitoba’s Health Research Ethics Board and will take about 5 to 10 minutes to complete. Continue reading
Today is the 5th annual Bell Let’s Talk Day, with Clara Hughes leading the campaign inviting all Canadians to talk, text and tweet and share on Facebook about mental health and help build a Canada free of the stigma of mental illness.
In a press release yesterday, Clara, Canada’s 6-time Olympic medalist and national Bell Let’s Talk ambassador since the launch of the initiative in 2010, said: “I’m really looking forward to kicking off the national conversation about mental health with Bell Let’s Talk Day 2015! Join us in the fight against the stigma that makes most who struggle with mental illness reluctant to ask for help.”
Mental illness is associated with other diseases, one of which is a type of arthritis called fibromyalgia. Fibromyalgia is characterized primarily by chronic widespread pain (CWP) in the muscles, ligaments and tendons, and a heightened sensitivity to touch resulting in pain that can last for months.
The Cochrane Pain Palliative and Supportive Care Review Group is inviting adults aged 18 years and over, with fibromyalgia, to join in on a Tweetchat to discuss patient-preferred fibromyalgia outcomes.
The aim of the Tweetchat is to explore outcomes for use in patient-preferred outcomes, for use in template protocols for Cochrane systemic reviews on interventions for fibromyalgia in adults.
Below are the event details: Continue reading
Researchers announced that small fiber neuropathy, rather than central sensitization, may be the underlying cause of pain for people living with fibromyalgia. According to one researcher’s interview with MedPage Today, Xavier J. Caro, MD, of Northridge Hospital Medical Center in Northridge, Calif., skin biopsies revealed lower mean epidermal nerve fiber density among patients with fibromyalgia compared with controls at both the calf (5.8 versus. 7.4, P<0.0002) and thigh (9.3 versus 11.3, P<0.0007). The decreased epidermal nerve fiber density could indicate a peripheral nervous system injury contributing to pain. Continue reading
The Canadian Institute for the Relief of Pain and Disability (CIRPD) will be conducting a webinar tomorrow (April 16) at 11:00am PDT/2:00pm EDT on fibromyalgia. The webinar will feature Connie Leudtke, MA, RN-BC, Assistant Professor at Mayo Clinic College of Medicine and Nursing Supervisor at the Mayo Clinic Pain Rehabilitation Center and Mayo Fibromyalgia and Chronic Fatigue Clinic. Drawing from 25 years of experience, Leudtke will dispel some common myths about fibromyalgia. She will also provide up-to-date information on diagnosis and treatment.
At the end of the webinar, attendees will be able to: Continue reading